title: Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma.
authors.affiliation: Department of Anesthesia, Massachusetts General Hospital, Boston, MA 02114.
authors.forename: S
authors.initials: S
authors.lastname: Small
authors.forename: H H
authors.initials: HH
authors.lastname: Ali
authors.forename: V A
authors.initials: VA
authors.lastname: Lennon
authors.forename: R H
authors.initials: RH
authors.lastname: Brown
authors.forename: D B
authors.initials: DB
authors.lastname: Carr
authors.forename: A
authors.initials: A
authors.lastname: de Armendi
mesh_terms: D000230:Adenocarcinoma / Q000150:complications; D000368:Aged; D000758:Anesthesia; D000762:Anesthesia Recovery Period; D001323:Autoantibodies / Q000032:analysis*; D001932:Brain Neoplasms / Q000556:secondary; D015220:Calcium Channels / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000276:immunology* / Q000556:secondary; D004558:Electric Stimulation; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000175:diagnosis* / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology*; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000276:immunology; D009382:Neoplasms, Unknown Primary / Q000276:immunology*; D009469:Neuromuscular Junction / Q000187:drug effects; D012004:Rectal Neoplasms / Q000150:complications; D013390:Succinylcholine / Q000009:adverse effects; D014403:Tubocurarine / Q000009:adverse effects
chemical_list: D001323:Autoantibodies; D015220:Calcium Channels; D013390:Succinylcholine; D014403:Tubocurarine